| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268542A2 Therapeutic anti-melanoma compounds |
| 01/02/2003 | EP1268531A2 Method for the production of bacterial toxins |
| 01/02/2003 | EP1268529A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 01/02/2003 | EP1268525A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 01/02/2003 | EP1268524A2 Binding peptides for carcinoembryonic antigen (cea) |
| 01/02/2003 | EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 01/02/2003 | EP1268522A2 Novel lhrh-antagonists, production and use thereof as medicament |
| 01/02/2003 | EP1268521A1 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268520A2 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268519A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/02/2003 | EP1268518A1 Insulin potentiating peptides |
| 01/02/2003 | EP1268497A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 01/02/2003 | EP1267924A2 Immunotherapeutic methods and compositions |
| 01/02/2003 | EP1267908A1 Vaccine for the treatment of atherosclerosis |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/02/2003 | EP0948526A4 Contryphan peptides |
| 01/02/2003 | EP0910574B1 Method for discovering novel anthelmintic compounds |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0625988B1 Allosteric modulators of the nmda receptor |
| 12/31/2002 | US6500934 Bivalent agonists for G-protein coupled receptors |
| 12/31/2002 | US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications |
| 12/31/2002 | US6500436 Administering botulinium toxin component coupled to substance p |
| 12/27/2002 | WO2002103016A2 Human tachykinin-related splice variants and compositions thereof |
| 12/27/2002 | WO2002102996A1 Male contraceptives |
| 12/27/2002 | WO2002102835A2 Novel antimicrobial compounds |
| 12/27/2002 | WO2002102832A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002072619A9 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE |
| 12/27/2002 | WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy |
| 12/27/2002 | WO2001034631A3 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 12/27/2002 | CA2455387A1 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | CA2449909A1 Male contraceptives |
| 12/27/2002 | CA2445261A1 Human tachykinin-related splice variants and compositions thereof |
| 12/26/2002 | US20020198364 Protein for use in controlling reproduction and fertility in humans |
| 12/26/2002 | US20020198360 Structural models for cytoplasmic domains of transmembrane receptors |
| 12/26/2002 | US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 12/26/2002 | US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 12/26/2002 | US20020198142 Integrin inhibitors, for the treatment of disorders caused by implants, defects, inflammations and of osteolytic disorders such as osteoporosis, thrombosis, cardiac infarct and arteriosclerosis |
| 12/26/2002 | US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes |
| 12/25/2002 | CN1387578A Novel compound F-15078 |
| 12/25/2002 | CN1386754A Non-T cell conjugating peptide and its use |
| 12/24/2002 | CA2147863C Determination of peptide motifs on mhc molecules |
| 12/24/2002 | CA2087261C Purification directed cloning of peptides |
| 12/24/2002 | CA2075878C Cyclic peptides and use thereof |
| 12/19/2002 | WO2002101040A1 Human-type anti-blood coagulation factor viii antibody |
| 12/19/2002 | WO2002100888A1 Somatostatin-dopamine chimeric analogs |
| 12/19/2002 | WO2002100885A2 A penta- or tetrapeptide binding to somatostatin receptors and the use of the same |
| 12/19/2002 | WO2002100883A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 12/19/2002 | WO2002028887A3 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 12/19/2002 | WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof |
| 12/19/2002 | WO2001068679A9 Peptides targeting specifically tumor-derived endothelial cells |
| 12/19/2002 | US20020193560 Cyclic polypeptide compound for use as microbiocide |
| 12/19/2002 | US20020193310 For therapy of hyperglycemic disorders |
| 12/19/2002 | US20020192789 Novel enterokinase cleavage sequences |
| 12/19/2002 | US20020192780 Novel anti-inflammatory peptides |
| 12/19/2002 | US20020192773 Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby |
| 12/19/2002 | US20020192705 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells |
| 12/19/2002 | US20020192693 Apparatus for polymer synthesis |
| 12/19/2002 | US20020192232 Methods and compositions for impairing multiplication of HIV-1 |
| 12/19/2002 | CA2449631A1 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 12/19/2002 | CA2418808A1 Human-type anti-blood coagulation factor viii antibody |
| 12/18/2002 | EP1266662A2 Synthetic peptide vaccines for dental caries |
| 12/18/2002 | EP1265916A2 Therapeutic anti-cytomegalovirus compounds |
| 12/18/2002 | EP1265849A2 Compounds and methods to treat alzheimer's disease |
| 12/18/2002 | EP0973801B1 GnRH ANTAGONISTS |
| 12/18/2002 | EP0934431B1 Method and cellculture for identifying inhibitors of eukaryotic cell processes |
| 12/18/2002 | EP0630255B1 Mhc conjugates useful in ameliorating autoimmunity |
| 12/17/2002 | US6495666 Polypeptide composing human chimeric antibody |
| 12/17/2002 | US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein |
| 12/17/2002 | US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting |
| 12/17/2002 | CA2108977C Luteinizing hormone releasing hormone antagonist peptides |
| 12/17/2002 | CA2063106C Ciclosporin form for pulmonary administration |
| 12/12/2002 | WO2002099379A2 Breast homing peptides and methods of identifying same using aminopeptidase p |
| 12/12/2002 | WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/12/2002 | WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 12/12/2002 | WO2002099045A2 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 12/12/2002 | WO2002098912A2 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems |
| 12/12/2002 | WO2002098906A1 Methods and compositions for modulating ace-2 activity |
| 12/12/2002 | WO2002098448A1 Methods and compositions for modulating ace-2 activity |
| 12/12/2002 | WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 12/12/2002 | WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 12/12/2002 | WO2002074327A3 Compositions and methods for treating gonadotrophin related illnesses |
| 12/12/2002 | WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity |
| 12/12/2002 | WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures |
| 12/12/2002 | US20020188115 Reagents and methods useful for detecting diseases of the breast |
| 12/12/2002 | US20020188114 Nucleotide sequences coding polypeptide for use in the treatment, prevention, diagnosis, and classification of tumors |
| 12/12/2002 | US20020188103 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof |
| 12/12/2002 | US20020188102 Peptide for use as microbiocides |
| 12/12/2002 | US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease |
| 12/12/2002 | US20020187938 Ghrelin antagonists |
| 12/12/2002 | US20020187934 Peptide derivatives |
| 12/12/2002 | US20020187929 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides |
| 12/12/2002 | DE10147056A1 New pentapeptides containing 5-membered ring in the peptide chain, useful as apoptosis inducing antitumor agents, for treating neurological and/or inflammatory disorders or in tumor diagnosis |
| 12/12/2002 | CA2464511A1 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems |
| 12/12/2002 | CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 12/12/2002 | CA2448382A1 Use of hepcidin as a regulator of iron homeostasis |
| 12/12/2002 | CA2448051A1 Methods and compositions for modulating ace-2 activity |
| 12/12/2002 | CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |